$154 Million is the total value of New Leaf Venture Partners, L.L.C.'s 21 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $54,276,000 | -37.5% | 1,289,521 | 0.0% | 35.16% | -17.8% | |
| RALLYBIO CORPORATION | $17,377,000 | +8.2% | 2,301,603 | 0.0% | 11.26% | +42.2% | ||
| DCPH | DECIPHERA PHARMACEUTICALS INC | $15,906,000 | +41.9% | 1,209,571 | 0.0% | 10.30% | +86.5% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $12,367,000 | -17.9% | 1,553,661 | 0.0% | 8.01% | +7.9% | |
| SRRA | Buy | SIERRA ONCOLOGY INC | $12,057,000 | +199.7% | 219,251 | +74.7% | 7.81% | +293.9% |
| DICE THERAPEUTICS INC | $8,640,000 | -18.9% | 556,693 | 0.0% | 5.60% | +6.6% | ||
| HARP | HARPOON THERAPEUTICS INC | $6,029,000 | -61.6% | 3,156,699 | 0.0% | 3.91% | -49.5% | |
| PASG | PASSAGE BIO | $5,895,000 | -23.9% | 2,497,922 | 0.0% | 3.82% | +0.1% | |
| COGT | COGENT BIOSCIENCES INC. | $4,524,000 | +20.4% | 501,530 | 0.0% | 2.93% | +58.3% | |
| ALEC | ALECTOR INC | $3,450,000 | -28.7% | 339,569 | 0.0% | 2.24% | -6.3% | |
| AMYT | AMRYT PHARMA PLC | $3,144,000 | -15.5% | 449,737 | 0.0% | 2.04% | +11.1% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2,630,000 | -15.0% | 141,000 | 0.0% | 1.70% | +11.7% | |
| CMRX | CHIMERIX INC | $2,547,000 | -54.6% | 1,224,600 | 0.0% | 1.65% | -40.3% | |
| APTX | APTINYX INC | $1,836,000 | -75.4% | 3,290,079 | 0.0% | 1.19% | -67.7% | |
| Sell | RENOVACOR CORPORATION | $1,360,000 | -52.3% | 670,689 | -0.2% | 0.88% | -37.3% | |
| ARAV | ARAVIVE INC | $935,000 | -48.8% | 946,423 | 0.0% | 0.61% | -32.7% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $428,000 | -41.0% | 117,242 | 0.0% | 0.28% | -22.6% | |
| XFOR | X4 PHARMACEUTICALS INC | $323,000 | -44.9% | 335,000 | 0.0% | 0.21% | -27.7% | |
| ITRM | ITERUM THERAPEUTICS PLC | $292,000 | -43.5% | 1,456,303 | 0.0% | 0.19% | -25.9% | |
| AVRO | AVROBIO INC | $290,000 | -30.5% | 315,550 | 0.0% | 0.19% | -8.7% | |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $58,000 | -77.2% | 50,000 | 0.0% | 0.04% | -69.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.